Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

76.17 +2.12 (+2.86%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Corp. (NASDAQ: TWST) Near the Top of Equities by Percentage Gain on 11/17
Via Investor Brand Network
News headline image
Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Expands Express Genes Rapid Synthesis Service
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.